Nucleosides, Nucleotides & Nucleic Acids ( IF 1.1 ) Pub Date : 2022-08-09 , DOI: 10.1080/15257770.2022.2107217 Zhenyu Zhao 1 , Wenyu Cai 2 , Jing Xing 3 , Chenhui Zhao 4
Abstract
Inadequate vitamin D levels and vitamin D variants have been shown to be associated with breast cancer (BC), however the results are inconsistent. To reach a definitive conclusion the present meta-analysis was conducted. When compared to healthy controls, BC patients had reduced vitamin D levels (standard difference in means = −0.564, p = 0.003). The meta-analysis revealed that the FokI mutation was linked with an increased BC susceptibility (CC vs. TT: OR = 1.107, p = 0.001, CC vs. TC + TT: OR = 1.114, p = 0.020). There was no role of other VDR variants (BsmI, TaqI, and ApaI). FokI mutation and diminished vitamin D increase the likelihood of developing BC.
中文翻译:
较低的维生素 D 水平和 VDR 变异是乳腺癌的危险因素:更新的荟萃分析
摘要
维生素 D 水平不足和维生素 D 变体已被证明与乳腺癌 (BC) 相关,但结果并不一致。为了得出明确的结论,进行了本荟萃分析。与健康对照组相比,BC 患者的维生素 D 水平降低(平均值的标准差 = -0.564,p = 0.003)。荟萃分析显示FokI突变与 BC 易感性增加有关(CC 与 TT:OR = 1.107,p = 0.001,CC 与 TC + TT:OR = 1.114,p = 0.020)。没有其他 VDR 变体(BsmI、TaqI和ApaI)的作用。福克突变和维生素 D 减少会增加患 BC 的可能性。